Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 5.135
Filtrar
Más filtros

Intervalo de año de publicación
1.
Commun Biol ; 7(1): 1173, 2024 Sep 18.
Artículo en Inglés | MEDLINE | ID: mdl-39294212

RESUMEN

The essential L,D-transpeptidase of Mycobacterium tuberculosis (LdtMt2) catalyses the formation of 3 → 3 cross-links in cell wall peptidoglycan and is a target for development of antituberculosis therapeutics. Efforts to inhibit LdtMt2 have been hampered by lack of knowledge of how it binds its substrate. To address this gap, we optimised the isolation of natural disaccharide tetrapeptide monomers from the Corynebacterium jeikeium bacterial cell wall through overproduction of the peptidoglycan sacculus. The tetrapeptides were used in binding / turnover assays and biophysical studies on LdtMt2. We determined a crystal structure of wild-type LdtMt2 reacted with its natural substrate, the tetrapeptide monomer of the peptidoglycan layer. This structure shows formation of a thioester linking the catalytic cysteine and the donor substrate, reflecting an intermediate in the transpeptidase reaction; it informs on the mode of entrance of the donor substrate into the LdtMt2 active site. The results will be useful in design of LdtMt2 inhibitors, including those based on substrate binding interactions, a strategy successfully employed for other nucleophilic cysteine enzymes.


Asunto(s)
Mycobacterium tuberculosis , Peptidil Transferasas , Mycobacterium tuberculosis/enzimología , Cristalografía por Rayos X , Peptidil Transferasas/metabolismo , Peptidil Transferasas/química , Especificidad por Sustrato , Proteínas Bacterianas/química , Proteínas Bacterianas/metabolismo , Proteínas Bacterianas/genética , Peptidoglicano/metabolismo , Peptidoglicano/química , Dominio Catalítico , Modelos Moleculares , Pared Celular/metabolismo , Corynebacterium/enzimología
2.
BMC Infect Dis ; 24(1): 939, 2024 Sep 09.
Artículo en Inglés | MEDLINE | ID: mdl-39251918

RESUMEN

BACKGROUND: Corynebacterium striatum (C. striatum) is a gram-positive, anaerobic bacillus found both environmentally and in human skin and nasal mucosa flora. It is reportedly the etiologic agent of community-acquired and nosocomial diseases and is significantly associated with bacteremia and medical endovascular devices. This is the rare case of mitral valve native valve endocarditis (NVE) caused by C. striatum occurring in a young adult without underlying structural heart disease or indwelling cardiovascular medical devices successfully treated with multidisciplinary therapy. CASE PRESENTATION: The patient was a 28-year-old female with no medical history. She was transferred our hospital due to sudden onset of vertigo and vomit. A computed tomography on day 2 revealed the hydrocephalus due to the cerebellar infarction, and she underwent posterior fossa decompression for cerebellar infarction. An angiography on day 8 revealed a left vertebral artery dissection, which was suspected be the etiology. Afterwards, a sudden fever of 39 degrees developed on day 38. She was diagnosed with aspiration pneumonia and treated with ampicillin/sulbactam but was still febrile at the time of transfer for rehabilitation. Treatment continued with levofloxacin, the patient had no fever decline, and she was readmitted to our hospital. Readmission blood cultures (3/3 sets) revealed C. striatum, and an echocardiogram revealed an 11 mm long mitral valve vegetation, leading to NVE diagnosis. On the sixth illness day, cardiac failure symptoms manifested. Echocardiography revealed mitral valve rupture. She was transferred again on the 11th day of illness, during which time her mitral valve was replaced. C. striatum was detected in the vegetation. Following surgery, she returned to our hospital, and vancomycin administration continued. The patient was discharged after 31 total days of postoperative antimicrobial therapy. The patient experienced no exacerbations thereafter. CONCLUSIONS: We report the rare case of C. striatum mitral valve NVE in a young adult without structural heart disease or indwelling cardiovascular devices. CLINICAL TRIAL NUMBER: Not applicable.


Asunto(s)
Antibacterianos , Infecciones por Corynebacterium , Corynebacterium , Endocarditis Bacteriana , Humanos , Femenino , Adulto , Infecciones por Corynebacterium/microbiología , Infecciones por Corynebacterium/tratamiento farmacológico , Corynebacterium/aislamiento & purificación , Endocarditis Bacteriana/microbiología , Endocarditis Bacteriana/tratamiento farmacológico , Antibacterianos/uso terapéutico , Válvula Mitral/cirugía , Válvula Mitral/microbiología
3.
Invest Ophthalmol Vis Sci ; 65(11): 38, 2024 Sep 03.
Artículo en Inglés | MEDLINE | ID: mdl-39325471

RESUMEN

Purpose: The purpose of this study was to investigate the bacterial composition in the conjunctiva and to determine the relationship between fluoroquinolone resistance and mutations in the quinolone resistance-determining region (QRDR) in Corynebacterium macginleyi (C. macginleyi). Methods: Bacteria isolated from conjunctival swabs of patients awaiting ophthalmic surgery or patients with presumed keratoconjunctivitis were included in this study. For C. macginleyi isolates from 49 samples, the minimum inhibitory concentrations (MICs) of second- to fourth-generation fluoroquinolones were determined by broth microdilution. Additionally, we determined the sequence of the QRDR in the gyrA gene of C. macginleyi-positive isolates by direct sequencing and investigated the relationship between the QRDR mutation and the MICs of fluoroquinolones for C. macginleyi. Results: Among 423 eyes of 296 preoperative patients who underwent conjunctival culture testing, 105 eyes of 89 patients were culture-positive, and among 148 eyes of 147 patients with keratoconjunctivitis, 55 eyes of 54 patients were culture-positive. C. macginleyi accounted for the largest proportion of cultured organisms (34.8%). C. macginleyi-positive isolates were found in 45 eyes of 37 preoperative patients and in 4 eyes of 4 patients with keratoconjunctivitis. Direct sequencing revealed that 91.8% of C. macginleyi-positive isolates had amino acid mutations in the QRDR and 95.5% of mutations were found at Ser-87 and Asp-91. Isolates harboring double mutations at Ser-87 and Asp-91 were resistant to second- to fourth-generation fluoroquinolones. One isolate with double mutations at Ser-87 and Ala-88 but no mutation in Asp-91 showed intermediate susceptibility to moxifloxacin, a fourth-generation fluoroquinolone. Conclusions: C. macginleyi isolated from conjunctiva harboring QRDR amino acid mutations were resistant to second- to fourth-generation fluoroquinolones.


Asunto(s)
Antibacterianos , Conjuntiva , Infecciones por Corynebacterium , Corynebacterium , Girasa de ADN , Farmacorresistencia Bacteriana , Fluoroquinolonas , Pruebas de Sensibilidad Microbiana , Mutación , Humanos , Fluoroquinolonas/farmacología , Fluoroquinolonas/uso terapéutico , Corynebacterium/genética , Corynebacterium/efectos de los fármacos , Corynebacterium/aislamiento & purificación , Conjuntiva/microbiología , Antibacterianos/farmacología , Farmacorresistencia Bacteriana/genética , Infecciones por Corynebacterium/microbiología , Infecciones por Corynebacterium/tratamiento farmacológico , Girasa de ADN/genética , Masculino , Femenino , Queratoconjuntivitis/microbiología , Queratoconjuntivitis/tratamiento farmacológico , Queratoconjuntivitis/genética , Infecciones Bacterianas del Ojo/microbiología , Infecciones Bacterianas del Ojo/tratamiento farmacológico , Persona de Mediana Edad , Adulto , Anciano , ADN Bacteriano/genética , Moxifloxacino/farmacología , Moxifloxacino/uso terapéutico
4.
Proc Natl Acad Sci U S A ; 121(37): e2408654121, 2024 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-39226354

RESUMEN

Organisms display an immense variety of shapes, sizes, and reproductive strategies. At microscopic scales, bacterial cell morphology and growth dynamics are adaptive traits that influence the spatial organization of microbial communities. In one such community-the human dental plaque biofilm-a network of filamentous Corynebacterium matruchotii cells forms the core of bacterial consortia known as hedgehogs, but the processes that generate these structures are unclear. Here, using live-cell time-lapse microscopy and fluorescent D-amino acids to track peptidoglycan biosynthesis, we report an extraordinary example of simultaneous multiple division within the domain Bacteria. We show that C. matruchotii cells elongate at one pole through tip extension, similar to the growth strategy of soil-dwelling Streptomyces bacteria. Filaments elongate rapidly, at rates more than five times greater than other closely related bacterial species. Following elongation, many septa form simultaneously, and each cell divides into 3 to 14 daughter cells, depending on the length of the mother filament. The daughter cells then nucleate outgrowth of new thinner vegetative filaments, generating the classic "whip handle" morphology of this taxon. Our results expand the known diversity of bacterial cell cycles and help explain how this filamentous bacterium can compete for space, access nutrients, and form important interspecies interactions within dental plaque.


Asunto(s)
Peptidoglicano , Peptidoglicano/metabolismo , Corynebacterium/metabolismo , Corynebacterium/crecimiento & desarrollo , Biopelículas/crecimiento & desarrollo , División Celular , Humanos , Placa Dental/microbiología
5.
BMC Infect Dis ; 24(1): 988, 2024 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-39289626

RESUMEN

BACKGROUND: Corynebacterium striatum (C. striatum), a common skin and mucosal colonizer, is increasingly considered as an opportunistic pathogen causing bloodstream infections (BSIs). This study aims to investigate the clinical features and outcomes of C. striatum-BSI. METHODS: We included hospitalized cases with C. striatum-positive blood cultures from January 2014 to June 2022 and classified them into C. striatum-BSI group and contamination group; Clinical characteristics, treatments, and outcomes were compared between the C. striatum-BSI group and contamination group, Methicillin-resistant Staphylococcus aureus (MRSA)-BSI and Methicillin-resistant Staphylococcus epidermidis (MRSE)-BSI. RESULTS: Fifty-three patients with positive C. striatum blood cultures were identified. Among them, 25 patients were classified as C. striatum-BSI, with 21 as contamination cases. And 62 cases of MRSA-BSI and 44 cases of MRSE-BSI were identified. Compared to the contaminated group, the C. striatum-BSI group had a shorter time to positivity of blood cultures (27.0 h vs. 42.5 h, P = 0.011). C. striatum-BSI group had a longer time to positivity (27 h) when compared to both the MRSA (20 h) and MRSE groups (19 h) (p < 0.05). Appropriate therapy within 24 h of BSI onset was significantly lower in the C. striatum group (28%) compared to the MRSA (64.5%) and MRSE (65.9%) groups (p < 0.005). The 28-day mortality was higher in the C. striatum group (52.0%) compared to the MRSA (25.8%) and MRSE (18.2%) groups.  CONCLUSIONS: Given the distinct characteristics of C. striatum-BSI, including a longer time to positivity than other Gram-positive bacteria and higher mortality rates, we suggest prescribing early appropriate antibiotics if C. striatum-BSI is suspected.


Asunto(s)
Bacteriemia , Infecciones por Corynebacterium , Corynebacterium , Staphylococcus aureus Resistente a Meticilina , Humanos , Corynebacterium/aislamiento & purificación , Corynebacterium/clasificación , Corynebacterium/genética , Masculino , Femenino , Persona de Mediana Edad , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Infecciones por Corynebacterium/microbiología , Infecciones por Corynebacterium/tratamiento farmacológico , Bacteriemia/microbiología , Bacteriemia/tratamiento farmacológico , Bacteriemia/mortalidad , Anciano , Staphylococcus epidermidis/aislamiento & purificación , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/mortalidad , Infecciones Estafilocócicas/tratamiento farmacológico , Adulto , Antibacterianos/uso terapéutico , Antibacterianos/farmacología , Estudios Retrospectivos , Anciano de 80 o más Años
6.
Przegl Epidemiol ; 78(2): 207-218, 2024 Sep 18.
Artículo en Inglés, Polaco | MEDLINE | ID: mdl-39295187

RESUMEN

BACKGROUND: Despite the fact that the last cases of fully-symptomatic diphtheria were recorded in Poland in 1996 and 2000, infections caused by non-toxin-producing strains of Corynebacterium still occur. According to the epidemiological reports from ECDC in the second half of 2022, there was an increase in the number of diphtheria cases in European Union countries. As a result, the current issue becomes the appropriate preparation of microbiological laboratories for the diagnosis of Corynebacterium microorganisms. OBJECTIVE: Reidentification of diphtheria bacilli isolated from clinical samples and to assess the drug susceptibility of C. diphtheriae strains isolated in Poland. MATERIAL AND METHODS: The subject of the research were 18 strains isolated from clinical samples in Poland in 2023. Microbiological and genetic methods were used for the reidentification of the strains. Drug susceptibility was assessed using the disk diffusion method, following the new EUCAST recommendations effective from 2023. RESULTS: It was confirmed that all examined strains belonged to the genus Corynebacterium. It was de-monstrated that C. diphtheriae strains proved to be susceptible to increased exposure to benzylpenicillin and cefotaxime. Results obtained using ciprofloxacin allowed categorizing the strains into the intermediate susceptibility category WZE, except for one strain which was resistant to this antibiotic. All tested bacterial strains were susceptible to erythromycin. The C. ulcerans strain exhibited a similar antibiotic resistance profile to penicillin, cefotaxime, and ciprofloxa-cin, with additional detection of resistance to clindamycin. The toxigenicity of the tested strains was excluded. CONCLUSIONS: Based on epidemiological data regarding the emergence of new cases of infections caused by Corynebacterium strains, it is advisable to prepare theoretically and practically laboratories for diagnostics to detect potentially toxigenic diphtheria bacilli. Effective methods for the microbiological diagnosis of diphtheria bacilli are available. It is recommended to monitor the susceptibility to antimicrobial agents in all C. diphtheriae isolates.


Asunto(s)
Antibacterianos , Corynebacterium diphtheriae , Corynebacterium , Difteria , Pruebas de Sensibilidad Microbiana , Humanos , Polonia/epidemiología , Corynebacterium diphtheriae/aislamiento & purificación , Corynebacterium diphtheriae/efectos de los fármacos , Corynebacterium diphtheriae/genética , Difteria/microbiología , Difteria/epidemiología , Corynebacterium/aislamiento & purificación , Corynebacterium/efectos de los fármacos , Corynebacterium/genética , Antibacterianos/farmacología , Infecciones por Corynebacterium/microbiología , Infecciones por Corynebacterium/epidemiología , Infecciones por Corynebacterium/tratamiento farmacológico
7.
Future Microbiol ; 19(11): 963-970, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39109653

RESUMEN

Non-diphtheroid Corynebacterium sepsis is rare and has affected only immunocompromised or particularly predisposed patients so far. We present the first case of urosepsis caused by Corynebacterium aurimucosum in a 67-year-old woman, without any known immunodeficiencies and in absence of any immunosuppressive therapy, admitted to the hospital for fever and acute dyspnea. This work suggests a new approach in evaluating the isolation of Corynebacteria, especially if isolated from blood. In particular, it highlights the potential infectious role of C. aurimucosum (often considered a contaminant and only rarely identified as an etiological agent of infections) and its clinical consequences, detailing also interesting aspects about its microbiological diagnosis and relative therapy and clarifying contrasting data of literature.


[Box: see text].


Asunto(s)
Infecciones por Corynebacterium , Corynebacterium , Sepsis , Infecciones Urinarias , Humanos , Corynebacterium/aislamiento & purificación , Corynebacterium/genética , Corynebacterium/patogenicidad , Corynebacterium/clasificación , Anciano , Femenino , Infecciones por Corynebacterium/microbiología , Infecciones por Corynebacterium/diagnóstico , Infecciones por Corynebacterium/tratamiento farmacológico , Sepsis/microbiología , Sepsis/tratamiento farmacológico , Infecciones Urinarias/microbiología , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/diagnóstico , Antibacterianos/uso terapéutico
8.
Res Vet Sci ; 179: 105396, 2024 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-39213744

RESUMEN

Although diphtheria is a vaccine-preventable disease, numerous cases are still reported around the world, as well as outbreaks in countries, including European ones. Species of the Corynebacterium diphtheriae complex are potentially toxigenic and, therefore, must be considered given the possible consequences, such as the circulation of clones and transmission of antimicrobial resistance and virulence genes. Recently, Corynebacterium rouxii was characterized and included among the valid species of the complex. Therefore, two cases of C. rouxii infection arising from infections in domestic animals are presented here. We provide molecular characterization, phylogenetic analyses, genome sequencing, and CRISPR-Cas analyses to contribute to a better understanding of the molecular bases, pathogenesis, and epidemiological monitoring of this species, which is still little studied. We confirmed its taxonomic position with genome sequencing and in silico analysis and identified the ST-918 for both strains. The clinical isolates were sensitive resistance to benzylpenicillin and rifampin. Antimicrobial resistance genes, including tetB, rpoB2, and rbpA genes, were predicted. The bla and ampC genes were not found. Several virulence factors were also detected, including adhesion, iron uptake systems, gene regulation (dtxR), and post-translational modification (MdbA). Finally, one prophage and the Type I-E CRISPR-Cas system were identified.


Asunto(s)
Antibacterianos , Infecciones por Corynebacterium , Corynebacterium , Enfermedades de los Perros , Filogenia , Rifampin , Animales , Corynebacterium/genética , Corynebacterium/efectos de los fármacos , Enfermedades de los Perros/microbiología , Perros , Rifampin/farmacología , Infecciones por Corynebacterium/veterinaria , Infecciones por Corynebacterium/microbiología , Antibacterianos/farmacología , Genoma Bacteriano , Farmacorresistencia Bacteriana/genética , Penicilinas/farmacología
9.
Int J Mol Sci ; 25(13)2024 Jul 04.
Artículo en Inglés | MEDLINE | ID: mdl-39000472

RESUMEN

Melanin is produced by melanocytes to protect human skin from harmful ultraviolet radiation. During skin cell renewal, melanin and dead skin cells are disposed of. However, prolonged exposure to ultraviolet rays or aging can disturb this cycle, leading to skin hyperpigmentation due to melanin accumulation. Tyrosinase is a crucial enzyme involved in melanin biosynthesis. Although various compounds, including tyrosine inhibitors, that counteract melanin accumulation have been reported, some, such as hydroquinone, are toxic and can cause vitiligo. Meanwhile, the skin is the largest organ and the outermost layer of the immune system, containing a diverse range of bacteria that produce low-toxicity compounds. In the current study, we aim to identify metabolites produced by skin microbiota that inhibit tyrosinase. Specifically, mushroom tyrosinase served as the study model. Following commensal skin bacteria screening, Corynebacterium tuberculostearicum was found to inhibit tyrosinase activity. The active compound was cyclo(l-Pro-l-Tyr); commercially available cyclo(l-Pro-l-Tyr) also exhibited inhibitory activity. Docking simulations suggested that cyclo(l-Pro-l-Tyr) binds to the substrate-binding site of mushroom tyrosinase, obstructing the substrate pocket and preventing its activity. Hence, cyclo(l-Pro-l-Tyr) might have potential applications as a cosmetic agent and food additive.


Asunto(s)
Corynebacterium , Monofenol Monooxigenasa , Piel , Monofenol Monooxigenasa/antagonistas & inhibidores , Monofenol Monooxigenasa/metabolismo , Humanos , Piel/microbiología , Piel/efectos de los fármacos , Piel/metabolismo , Simulación del Acoplamiento Molecular , Agaricales/enzimología , Inhibidores Enzimáticos/farmacología , Péptidos Cíclicos/farmacología , Péptidos Cíclicos/química , Melaninas/metabolismo , Melaninas/biosíntesis
10.
J Agric Food Chem ; 72(30): 16877-16888, 2024 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-39038232

RESUMEN

Esterases are crucial for aryloxyphenoxypropionate herbicide (AOPP) biodegradation. However, the underlying molecular mechanisms of AOPP biodegradation by esterases are poorly understood. In the current work, Corynebacterium sp. Z-1 was isolated and found to degrade multiple AOPPs, including quizalofop-p-ethyl (QPE), haloxyfop-p-methyl (HPM), fenoxaprop-p-ethyl (FPE), cyhalofop-butyl (CYB), and clodinafop-propargyl (CFP). A novel esterase, QfeH, which catalyzes the cleavage of ester bonds in AOPPs to form AOPP acids, was identified from strain Z-1. The catalytic activities of QfeH toward AOPPs decreased in the following order: CFP > FPE > CYB > QPE > HPM. Molecular docking, computational analyses, and site-directed mutagenesis indicated the catalytic mechanisms of QfeH-mediated degradation of different AOPPs. Notably, the key residue S159 is essential for the activity of QfeH. Moreover, V222Y, T227M, T227A, A271R, and M275K mutants, exhibiting 2.9-5.0 times greater activity than QfeH, were constructed. This study facilitates the mechanistic understanding of AOPPs bioremediation by esterases.


Asunto(s)
Biodegradación Ambiental , Corynebacterium , Esterasas , Herbicidas , Herbicidas/metabolismo , Herbicidas/química , Esterasas/metabolismo , Esterasas/genética , Esterasas/química , Corynebacterium/metabolismo , Corynebacterium/genética , Corynebacterium/enzimología , Proteínas Bacterianas/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/química , Simulación del Acoplamiento Molecular , Propionatos/metabolismo
11.
Mikrobiyol Bul ; 58(3): 239-258, 2024 Jul.
Artículo en Turco | MEDLINE | ID: mdl-39046207

RESUMEN

An increasing number of different clinical infections caused by Corynebacteria have been reported in the last decade. The aim of this study was to evaluate the antibiotic resistance rates, biofilm formation capacities and to investigate the ''anti-quorum-sensing (anti-QS)'' activities of corynebacteria, which were divided into three groups according to the type of growth in culture (pure, with another pathogenic bacterium and polymicrobial growth). In total 240 Corynebacterium spp. isolates from different clinical specimens sent to the medical microbiology laboratories of Düzce University Faculty of Medicine Hospital and Basaksehir Çam and Sakura City Hospital between June 2021 and June 2022 were classified into three groups: pure, isolated with another pathogen and polymicrobial, according to their growth patterns in culture. Bacteria were identified by matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) Biotyper (Bruker, Germany) at an external centre. Antibiotic susceptibilities were determined by disc diffusion method and for vancomycin broth microdilution method was used. Results were interpreted according to EUCAST recommendations. The biofilm-forming properties of the isolates were determined quantitatively. Bioactive components of 17 isolates with strong biofilm formation were extracted and anti-QS activity was determined by agar diffusion method using Chromobacterium violaceum ATCC 12472 strain and then violacein pigment production was measured quantitatively. Of the 240 Corynebacterium spp. isolates, 138 (58%) were pure, 52 (22%) were isolated with another pathogen and 50 (20%) were part of a polymicrobial infection. Of the isolates, 140 were identified as C.striatum, 34 as C.amycolatum and 24 as Corynebacterium afermentans. When the antibiotic resistance rates of the Corynebacterium isolates were analysed according to the groups, the resistance rates to rifampicin and tetracycline antibiotics were found to be statistically significantly lower in the polymicrobial group than in the other groups. The resistance rates to penicillin, clindamycin, ciprofloxacin, moxifloxacin, rifampicin, tetracycline and linezolid were 96.7%, 88.3%, 86.3%, 73.8%, 62.5%, 59.2% and 0.8%, respectively. While all isolates were susceptible to vancomycin, linezolid resistance was detected in two C.afermentans isolates. When the biofilm formation ability was analysed, it was observed that 87 (36.3%) isolates formed biofilm. The biofilm formation rate of the isolates in the polymicrobial growth group was lower than the other two groups. The anti-QS activity of 17 isolates with strong biofilm formation was investigated and none of the Corynebacterium extracts tested were found to have anti-QS activity (inhibition of violacein pigment production without inhibiting bacterial growth) in the QS study with C.violaceum, whereas five isolate extracts had antibacterial activity (inhibition of bacterial growth). Four of the bacterial extracts with antimicrobial activity belonged to C.amycolatum and one to C.afermentans. In conclusion, when both antibiotic resistance rates and biofilm formation rates were analysed, the corynebacteria growing in culture with another pathogen showed similar characteristics to the corynebacteria growing as a pure culture. Therefore, it was thought that corynebacteria growing with another pathogen should not be ignored. In addition, the antimicrobial effects of some corynebacterial extracts suggested that more QS studies should be carried out with microbiota bacteria.


Asunto(s)
Antibacterianos , Biopelículas , Infecciones por Corynebacterium , Corynebacterium , Pruebas de Sensibilidad Microbiana , Percepción de Quorum , Biopelículas/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Corynebacterium/efectos de los fármacos , Corynebacterium/aislamiento & purificación , Corynebacterium/crecimiento & desarrollo , Humanos , Antibacterianos/farmacología , Infecciones por Corynebacterium/microbiología , Percepción de Quorum/efectos de los fármacos , Farmacorresistencia Bacteriana , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Indoles/farmacología
12.
Sci Rep ; 14(1): 16739, 2024 07 20.
Artículo en Inglés | MEDLINE | ID: mdl-39033201

RESUMEN

The aim of this study was to assess the profile of nasal microbiome and evaluate the effect of a specific nasal decolonization solution on the microbiome. We conducted a randomized, placebo-controlled, and parallel-group clinical study of 50 volunteers aged 18 years and older. The subjects were randomly assigned to receive a nasal antiseptic solution, containing povidone-iodine as the main ingredient, (n = 25) or a control solution (n = 25). Nasal swabs were obtained before application (baseline) and at 3 timepoints after application (5 min, 2 h, 24 h). Nasal swabs were subjected to next generation sequencing analysis and cultured in agar plates. At baseline, there were substantial associations between anaerobic species, Corynebacterium spp., Staphylococcus spp., and Dolosigranulum spp. Then, a high bioburden reduction was observed after the application of povidone-iodine (log10 3.68 ± 0.69 at 5 min; log10 3.57 ± 0.94 at 2 h; log10 1.17 ± 1.40 at 24 h), compared to the control. The top species affected by the treatment were Cutibacterium acnes, Staphylococcus, and Corynebacterium species. None of the subjects experienced any adverse effects, nor increases in mucociliary clearance time. Antiseptic solutions applied to the anterior nares can transiently and markedly reduce the bioburden of the nose. The registration number for this clinical trial is NCT05617729.


Asunto(s)
Antiinfecciosos Locales , Microbiota , Povidona Yodada , Humanos , Povidona Yodada/farmacología , Povidona Yodada/administración & dosificación , Antiinfecciosos Locales/farmacología , Antiinfecciosos Locales/administración & dosificación , Microbiota/efectos de los fármacos , Masculino , Femenino , Adulto , Estudios Prospectivos , Persona de Mediana Edad , Nariz/microbiología , Adulto Joven , Bacterias/efectos de los fármacos , Bacterias/clasificación , Bacterias/genética , Administración Intranasal , Corynebacterium/efectos de los fármacos
13.
Toxins (Basel) ; 16(6)2024 May 26.
Artículo en Inglés | MEDLINE | ID: mdl-38922140

RESUMEN

Diphtheria toxin (DT) is the main virulence factor of Corynebacterium diphtheriae, C. ulcerans and C. pseudotuberculosis. Moreover, new Corynebacterium species with the potential to produce diphtheria toxin have also been described. Therefore, the detection of the toxin is the most important test in the microbiological diagnosis of diphtheria and other corynebacteria infections. Since the first demonstration in 1888 that DT is a major virulence factor of C. diphtheriae, responsible for the systemic manifestation of the disease, various methods for DT detection have been developed, but the diagnostic usefulness of most of them has not been confirmed on a sufficiently large group of samples. Despite substantial progress in the science and diagnostics of infectious diseases, the Elek test is still the basic recommended diagnostic test for DT detection. The challenge here is the poor availability of an antitoxin and declining experience even in reference laboratories due to the low prevalence of diphtheria in developed countries. However, recent and very promising assays have been developed with the potential for use as rapid point-of-care testing (POCT), such as ICS and LFIA for toxin detection, LAMP for tox gene detection, and biosensors for both.


Asunto(s)
Toxina Diftérica , Difteria , Toxina Diftérica/genética , Humanos , Difteria/diagnóstico , Difteria/microbiología , Corynebacterium/genética , Corynebacterium diphtheriae
15.
J Magn Reson ; 364: 107708, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38901173

RESUMEN

Bacterial cell walls are gigadalton-large cross-linked polymers with a wide range of motional amplitudes, including rather rigid as well as highly flexible parts. Magic-angle spinning NMR is a powerful method to obtain atomic-level information about intact cell walls. Here we investigate sensitivity and information content of different homonuclear 13C13C and heteronuclear 1H15N, 1H13C and 15N13C correlation experiments. We demonstrate that a CPMAS CryoProbe yields ca. 8-fold increased signal-to-noise over a room-temperature probe, or a ca. 3-4-fold larger per-mass sensitivity. The increased sensitivity allowed to obtain high-resolution spectra even on intact bacteria. Moreover, we compare resolution and sensitivity of 1H MAS experiments obtained at 100 kHz vs. 55 kHz. Our study provides useful hints for choosing experiments to extract atomic-level details on cell-wall samples.


Asunto(s)
Isótopos de Carbono , Pared Celular , Pared Celular/química , Corynebacterium , Isótopos de Nitrógeno , Resonancia Magnética Nuclear Biomolecular/métodos , Espectroscopía de Resonancia Magnética/métodos , Relación Señal-Ruido
16.
Microbiol Spectr ; 12(7): e0344123, 2024 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-38864649

RESUMEN

This study aimed to characterize the composition of intestinal and nasal microbiota in septic patients and identify potential microbial biomarkers for diagnosis. A total of 157 subjects, including 89 with sepsis, were enrolled from the affiliated hospital. Nasal swabs and fecal specimens were collected from septic and non-septic patients in the intensive care unit (ICU) and Department of Respiratory and Critical Care Medicine. DNA was extracted, and the V4 region of the 16S rRNA gene was amplified and sequenced using Illumina technology. Bioinformatics analysis, statistical processing, and machine learning techniques were employed to differentiate between septic and non-septic patients. The nasal microbiota of septic patients exhibited significantly lower community richness (P = 0.002) and distinct compositions (P = 0.001) compared to non-septic patients. Corynebacterium, Staphylococcus, Acinetobacter, and Pseudomonas were identified as enriched genera in the nasal microbiota of septic patients. The constructed machine learning model achieved an area under the curve (AUC) of 89.08, indicating its efficacy in differentiating septic and non-septic patients. Importantly, model validation demonstrated the effectiveness of the nasal microecological diagnosis prediction model with an AUC of 84.79, while the gut microecological diagnosis prediction model had poor predictive performance (AUC = 49.24). The nasal microbiota of ICU patients effectively distinguishes sepsis from non-septic cases and outperforms the gut microbiota. These findings have implications for the development of diagnostic strategies and advancements in critical care medicine.IMPORTANCEThe important clinical significance of this study is that it compared the intestinal and nasal microbiota of sepsis with non-sepsis patients and determined that the nasal microbiota is more effective than the intestinal microbiota in distinguishing patients with sepsis from those without sepsis, based on the difference in the lines of nasal specimens collected.


Asunto(s)
Bacterias , Biomarcadores , Heces , Unidades de Cuidados Intensivos , Microbiota , ARN Ribosómico 16S , Sepsis , Humanos , Sepsis/diagnóstico , Sepsis/microbiología , Masculino , Femenino , Persona de Mediana Edad , Anciano , ARN Ribosómico 16S/genética , Biomarcadores/análisis , Bacterias/aislamiento & purificación , Bacterias/genética , Bacterias/clasificación , Heces/microbiología , Adulto , Aprendizaje Automático , Microbioma Gastrointestinal , Nariz/microbiología , Corynebacterium/aislamiento & purificación , Corynebacterium/genética , Acinetobacter/aislamiento & purificación , Acinetobacter/genética , Anciano de 80 o más Años , Staphylococcus/aislamiento & purificación , Staphylococcus/genética , Pseudomonas/aislamiento & purificación , Pseudomonas/genética
17.
J Glob Antimicrob Resist ; 38: 181-186, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38936471

RESUMEN

Herein, we combined different bioinformatics tools and databases (BV-BRC, ResFinder, RAST, and KmerResistance) to perform a prediction of antimicrobial resistance (AMR) in the genomic sequences of 107 Corynebacterium striatum isolates for which trustable antimicrobial susceptibility (AST) phenotypes could be retrieved. Then, the reliabilities of the AMR predictions were evaluated by different metrics: area under the ROC curve (AUC); Major Error Rates (MERs) and Very Major Error Rates (VMERs); Matthews Correlation Coefficient (MCC); F1-Score; and Accuracy. Out of 15 genes that were reliably detected in the C. striatum isolates, only tetW yielded predictive values for tetracycline resistance that were acceptable considering Food and Drug Administration (FDA)'s criteria for quality (MER < 3.0% and VMER with a 95% C.I. ≤1.5-≤7.5); this was accompanied by a MCC score higher than 0.9 for this gene. Noteworthy, our results indicate that other commonly used metrics (AUC, F1-score, and Accuracy) may render overoptimistic evaluations of AMR-prediction reliabilities on imbalanced datasets. Accordingly, out of 10 genes tested by PCR on additional multidrug-resistant Corynebacterium spp. isolates (n = 18), the tetW gene rendered the best agreement values with AST profiles (94.11%). Overall, our results indicate that genome-based AMR prediction can still be challenging for MDR clinical isolates of emerging Corynebacterium spp.


Asunto(s)
Antibacterianos , Biología Computacional , Corynebacterium , Farmacorresistencia Bacteriana Múltiple , Genoma Bacteriano , Pruebas de Sensibilidad Microbiana , Secuenciación Completa del Genoma , Corynebacterium/genética , Corynebacterium/efectos de los fármacos , Corynebacterium/aislamiento & purificación , Corynebacterium/clasificación , Farmacorresistencia Bacteriana Múltiple/genética , Antibacterianos/farmacología , Humanos , Infecciones por Corynebacterium/microbiología
18.
Cancer Sci ; 115(8): 2738-2750, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38888048

RESUMEN

Pancreatic head cancer (PHC) and pancreatic body/tail cancer (PBTC) have distinct clinical and biological behaviors. The microbial and metabolic differences in PHC and PBTC have not been studied. The pancreatic microbiota and metabolome of 15 PHC and 8 PBTC tissues and their matched nontumor tissues were characterized using 16S rRNA amplicon sequencing and untargeted metabolomics. At the genus level, Bradyrhizobium was increased while Corynebacterium and Ruminococcus were decreased in the PHC tissues (Head T) compared with the matched nontumor tissues (Head N) significantly. Shuttleworthia, Bacillus, and Bifidobacterium were significantly decreased in the PBTC tissues (Body/Tail T) compared with the matched nontumor tissues (Body/Tail N). Significantly, Ileibacterium was increased whereas Pseudoxanthomonas was decreased in Head T and Body/Tail T, and Lactobacillus was increased in Head T but decreased in Body/Tail T. A total of 102 discriminative metabolites were identified between Head T and Head N, which were scattered through linoleic acid metabolism and purine metabolism pathways. However, there were only four discriminative metabolites between Body/Tail T and Body/Tail N, which were related to glycerophospholipid metabolism and autophagy pathways. The differential metabolites in PHC and PBTC were commonly enriched in alpha-linolenic acid metabolism and choline metabolism in cancer pathways. Eubacterium decreased in Head T was positively correlated with decreased linoleic acid while negatively correlated with increased arachidyl carnitine and stearoylcarnitine. Bacillus decreased in Body/Tail T was negatively correlated with increased L-carnitine. These microbiota and metabolites deserve further investigations to reveal their roles in the pathogenesis of PHC and PBTC, providing clues for future treatments.


Asunto(s)
Neoplasias Pancreáticas , ARN Ribosómico 16S , Humanos , Neoplasias Pancreáticas/microbiología , Neoplasias Pancreáticas/metabolismo , Masculino , Persona de Mediana Edad , Femenino , Anciano , ARN Ribosómico 16S/genética , Metaboloma , Microbiota , Metabolómica/métodos , Páncreas/metabolismo , Páncreas/microbiología , Corynebacterium/metabolismo , Corynebacterium/genética
19.
J Biotechnol ; 392: 25-33, 2024 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-38876312

RESUMEN

Bioaromas can be produced by lipases either through their hydrolytic or (trans)esterifying activities. Therefore, this work reports the development of a lipase-catalyzed biotransformed licuri oil, forming volatile ethyl esters with odor notes resembling tropical fruits. Ethyl octanoate formation was promoted when 7.0 % (m/v) Lipozyme 435® was used to convert a grain alcohol:licuri oil mixture (51:49, v/v) at 58ºC and 70 rpm for 6 hours. The biotransformed oil has shown antimicrobial activity against Staphylococcus hominis, S. epidermidis, and Corynebacterium xerosis, bacteria associated with bad skin odor. Finally, this biotransformed oil was used without further treatments (e.g., recovery or purification procedures) to prepare two cosmetic formulations (in a dosage of 1.5 %), aiming for both fragrant and deodorant activity.


Asunto(s)
Cosméticos , Lipasa , Aceites de Plantas , Lipasa/metabolismo , Cosméticos/química , Aceites de Plantas/química , Aceites de Plantas/metabolismo , Ésteres/química , Ésteres/metabolismo , Corynebacterium , Biotransformación
20.
Eur J Clin Microbiol Infect Dis ; 43(7): 1495-1501, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38801486

RESUMEN

Corynebacterium striatum is an emerging nosocomial pathogen. This is the first report showing the presence of three distinct multidrug resistant lineages of C. striatum among patients in a UK hospital. The presence of ErmX, Tet(W), Bla and AmpC proteins, and mutations in gyrA gene are associated with the resistance to clindamycin, doxycycline, penicillin and moxifloxacin, respectively. These strains are equipped with several corynebacterial virulence genes including two SpaDEF-type and a novel pilus gene cluster, which needs further molecular characterisation. This study highlights a need of developing an active surveillance strategy for routine monitoring and preventing potential cross-transmission among susceptible patients.


Asunto(s)
Antibacterianos , Infecciones por Corynebacterium , Corynebacterium , Farmacorresistencia Bacteriana Múltiple , Filogenia , Centros de Atención Terciaria , Humanos , Corynebacterium/genética , Corynebacterium/efectos de los fármacos , Corynebacterium/aislamiento & purificación , Corynebacterium/clasificación , Farmacorresistencia Bacteriana Múltiple/genética , Infecciones por Corynebacterium/microbiología , Infecciones por Corynebacterium/epidemiología , Reino Unido/epidemiología , Antibacterianos/farmacología , Pruebas de Sensibilidad Microbiana , Infección Hospitalaria/microbiología , Infección Hospitalaria/epidemiología , Masculino , Factores de Virulencia/genética , Proteínas Bacterianas/genética , Femenino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA